Cachexia is a wasting syndrome characterized by weight loss. Cachexia is associated with chronic inflammatory conditions and cancer. It is a multifactorial syndrome characterized by loss of body weight, anorexia, anemia, and asthenia. It is more prevalent in patients with tumors of the lung, pancreas, and upper gastrointestinal tract as well as oral cancer patients. According to statistics, incidence of cachexia is high in developed regions such as North America, Europe, and Japan. Nearly 9 million individuals are affected by cachexia across the world. In the U.S., approximately 5 million individuals are affected by cachexia. The prevalence rate of cachexia varies from 5% to 15% in end-stage chronic heart failure to 50% to 80% in progressive cancer. The average mortality rate of cachexia for chronic obstructive pulmonary disease (COPD) is nearly 10% to 15%; 20% to 30% in individuals with chronic heart failure and chronic kidney disease, and approximately 80% in cancer patients. 

The global oral cachexia nutrition supplementation market is driven by increase in incidence of chronic diseases such as cancer, chronic obstructive pulmonary disease, and tuberculosis among individuals, rise in health care expenditure in developing and developed countries, surge in awareness about nutritional supplements, and rise in product approvals. However; limited availability of products in certain parts of the globe, high cost, and risk of side effects if not administered adequately act as major restraints of the global market. 

The global oral cachexia nutrition supplementation market can be segmented based on dosage form, indication, distribution channel, and region. In terms of dosage form, the market can be bifurcated into powder and liquid. Based on indication, the global oral cachexia nutrition supplementation market can be divided into chronic obstructive pulmonary disease (COPD), cancer, tuberculosis, AIDS, and others. In terms of distribution channel, the market can be categorized into hospital pharmacies, retail pharmacies, and online pharmacies. 

The global oral cachexia nutrition supplementation market can be segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America and Europe are projected to dominate the global market in terms of share during the forecast period. This is attributed to increase in incidence of chronic diseases, rise in health care expenditure, presence of major manufacturers, and surge in demand. Asia Pacific is anticipated to present lucrative opportunities in the oral cachexia nutrition supplementation market owing to increase in patient population, rise in awareness about nutritional supplements, surge in mergers & acquisitions, and improving health care infrastructure in developing countries. The market in Latin America and Middle East & Africa is expected to be driven by increase in spending capabilities, rise in investment in health care, favorable government support programs for spreading awareness, and adoption of expansion strategies by manufacturers in these regions through strategic collaborations with regional and local manufacturers & distributors to increase product availability. 

Major players operating in the global oral cachexia nutrition supplementation market include Abbott Laboratories, Danone Nutricia, Nestle, Prodiet Clinical Nutrition, Mead Johnson & Company, LLC, and Other Prominent Players.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market   

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

.